Virtual Care's Role in Behavioral Health — Opportunities and Risks Highlighted Based on Recent Data
Virtual care offers a significant opportunity to bridge the gap between supply and demand in behavioral health services. However, there are risks associated with the lack of integration between virtual care and traditional healthcare systems, particularly in medication management.
Sanjula Jain, Ph.D., chief research officer at Trilliant recently spoke with Managed Healthcare Executive about the distinct role of virtual care, particularly in behavioral health.
Based off of recent studies published by Trilliant Health, Jain pointed out that virtual care is most effective for "low acuity behavioral health" and stressed the importance of differentiating between long-term care delivery relationships and more transactional, direct-to-consumer models.
Virtual care offers a significant opportunity to bridge the gap between supply and demand in behavioral health services, she shared. However, there are risks associated with the lack of integration between virtual care and traditional healthcare systems, particularly in medication management.
Related: Research Finds Virtual Care as Convenient but May Fail to Build Long-Term Patient Connections
“There is probably more focus on the care delivery relationship piece that providers should really be thinking about when it comes to medication management,” she said.
She also suggested that virtual care could be used to identify comorbidities and create referral relationships for higher acuity needs but noted it’s a broader challenge not limited to virtual care alone.
Related: Hospitals Should Consider Clinical Use, Payment Parity When Investing in Telehealth Post-Pandemic
Jain told MHE editors she sees virtual care as a tool with the potential to enhance patient engagement and access to necessary services, though it requires careful implementation to ensure comprehensive care.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
